Alberta Investment Management Corp Ascendis Pharma A/S Transaction History

Alberta Investment Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$104.9 - $126.78 $1.1 Million - $1.33 Million	-10,454 Reduced 17.28%	50,031 $5.36 Million
Q4 2022 Feb 14, 2023	BUY	$99.42 - $131.97 $1.31 Million - $1.74 Million	13,205 Added 27.93%	60,485 $7.39 Million
Q3 2022 Nov 14, 2022	SELL	$84.03 - $110.23 $77,139 - $101,191	-918 Reduced 1.9%	47,280 $4.88 Million
Q2 2022 Aug 15, 2022	SELL	$78.08 - $117.61 $479,255 - $721,890	-6,138 Reduced 11.3%	48,198 $4.48 Million
Q4 2021 Feb 11, 2022	BUY	$127.1 - $169.66 $6.91 Million - $9.22 Million	54,336 New	54,336 $7.31 Million

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Alberta Investment Management Corp with notifications on news.